Apparently a divergent chaperone with distant Eukaryotic affinities. Topology is very unclear. Likely non-TM
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: Q4Q6N7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 44 | 48 | PF00656 | 0.630 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.674 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.666 |
CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.530 |
CLV_PCSK_PC1ET2_1 | 94 | 96 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.665 |
CLV_PCSK_SKI1_1 | 233 | 237 | PF00082 | 0.650 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.401 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.609 |
DEG_SPOP_SBC_1 | 89 | 93 | PF00917 | 0.605 |
DOC_MAPK_gen_1 | 241 | 249 | PF00069 | 0.488 |
DOC_MAPK_JIP1_4 | 216 | 222 | PF00069 | 0.397 |
DOC_PP1_RVXF_1 | 165 | 172 | PF00149 | 0.455 |
DOC_PP2B_LxvP_1 | 220 | 223 | PF13499 | 0.544 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.578 |
DOC_USP7_MATH_1 | 254 | 258 | PF00917 | 0.464 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.689 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.531 |
DOC_USP7_MATH_1 | 60 | 64 | PF00917 | 0.701 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.605 |
LIG_14-3-3_CanoR_1 | 108 | 117 | PF00244 | 0.672 |
LIG_14-3-3_CanoR_1 | 135 | 144 | PF00244 | 0.597 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.588 |
LIG_14-3-3_CanoR_1 | 268 | 273 | PF00244 | 0.509 |
LIG_14-3-3_CanoR_1 | 64 | 74 | PF00244 | 0.625 |
LIG_APCC_ABBAyCdc20_2 | 95 | 101 | PF00400 | 0.615 |
LIG_BIR_III_2 | 59 | 63 | PF00653 | 0.534 |
LIG_BRCT_BRCA1_1 | 145 | 149 | PF00533 | 0.600 |
LIG_BRCT_BRCA1_1 | 2 | 6 | PF00533 | 0.543 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.584 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.613 |
LIG_FHA_2 | 30 | 36 | PF00498 | 0.610 |
LIG_FHA_2 | 42 | 48 | PF00498 | 0.537 |
LIG_Integrin_RGD_1 | 283 | 285 | PF01839 | 0.630 |
LIG_LIR_Apic_2 | 138 | 144 | PF02991 | 0.647 |
LIG_LIR_Gen_1 | 178 | 186 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.378 |
LIG_NRBOX | 179 | 185 | PF00104 | 0.323 |
LIG_SH2_GRB2like | 125 | 128 | PF00017 | 0.625 |
LIG_SH2_STAP1 | 137 | 141 | PF00017 | 0.659 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.623 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.374 |
LIG_SUMO_SIM_anti_2 | 246 | 251 | PF11976 | 0.500 |
LIG_SUMO_SIM_par_1 | 268 | 273 | PF11976 | 0.495 |
LIG_TRAF2_1 | 150 | 153 | PF00917 | 0.632 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.709 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.536 |
MOD_CK1_1 | 257 | 263 | PF00069 | 0.421 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.489 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.778 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.615 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.565 |
MOD_CK2_1 | 37 | 43 | PF00069 | 0.572 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.558 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.499 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.470 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.423 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.445 |
MOD_GlcNHglycan | 272 | 275 | PF01048 | 0.704 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.549 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.567 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.411 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.526 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.538 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.504 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.614 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.559 |
MOD_N-GLC_1 | 126 | 131 | PF02516 | 0.430 |
MOD_N-GLC_1 | 65 | 70 | PF02516 | 0.406 |
MOD_N-GLC_1 | 78 | 83 | PF02516 | 0.390 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.566 |
MOD_NEK2_1 | 270 | 275 | PF00069 | 0.493 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.488 |
MOD_PK_1 | 268 | 274 | PF00069 | 0.430 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.584 |
MOD_PKA_2 | 144 | 150 | PF00069 | 0.692 |
MOD_PKA_2 | 257 | 263 | PF00069 | 0.397 |
MOD_PKB_1 | 188 | 196 | PF00069 | 0.433 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.731 |
MOD_SUMO_rev_2 | 285 | 294 | PF00179 | 0.418 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.291 |
TRG_ER_diArg_1 | 187 | 190 | PF00400 | 0.408 |
TRG_Pf-PMV_PEXEL_1 | 233 | 237 | PF00026 | 0.732 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P346 | Leptomonas seymouri | 27% | 79% |
A0A0N1I1W6 | Leptomonas seymouri | 42% | 97% |
A0A3Q8IEI2 | Leishmania donovani | 28% | 74% |
A0A422P027 | Trypanosoma rangeli | 28% | 97% |
A4I4P7 | Leishmania infantum | 28% | 74% |
E9AE50 | Leishmania major | 29% | 74% |
E9ALN5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 74% |
E9B1H7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
V5BN31 | Trypanosoma cruzi | 32% | 96% |